137 related articles for article (PubMed ID: 18463433)
1. Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients.
Eleftheriadis T; Kartsios C; Yiannaki E; Kazila P; Antoniadi G; Liakopoulos V; Markala D
Blood Purif; 2008; 26(4):317-21. PubMed ID: 18463433
[TBL] [Abstract][Full Text] [Related]
2. Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in haemodialysis patients.
Eleftheriadis T; Kartsios C; Yiannaki E; Antoniadi G; Kazila P; Pliakos K; Liakopoulos V; Markala D
Nephrology (Carlton); 2009 Aug; 14(5):471-5. PubMed ID: 19486472
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients.
Eleftheriadis T; Kartsios C; Yiannaki E; Kazila P; Antoniadi G; Liakopoulos V; Markala D
Am J Nephrol; 2008; 28(1):152-7. PubMed ID: 17951997
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
[TBL] [Abstract][Full Text] [Related]
5. [Expression of zeta (zeta) chain in peripheral blood T lymphocytes and NK cells of children with idiopathic nephrotic syndrome (INS)--preliminary results].
Musiał K; Ciszak L; Kosmaczewska A; Szteblich A; Pawlak E; Zwolińska D; Frydecka I
Przegl Lek; 2006; 63 Suppl 3():208-10. PubMed ID: 16898532
[TBL] [Abstract][Full Text] [Related]
6. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Lai P; Rabinowich H; Crowley-Nowick PA; Bell MC; Mantovani G; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):161-73. PubMed ID: 9816103
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory, degenerative and vascular lesions in long-term dialysed patients.
Vrabie CD; Petrescu A; Waller M; Cojocaru M; Ciocâlteu A; Dina I
Rom J Intern Med; 2009; 47(2):149-59. PubMed ID: 20067165
[TBL] [Abstract][Full Text] [Related]
8. [Zeta chain level of T and NK cells in patients with renal-cell carcinoma and bladder cancer and its clinical significance].
Han Y; Li CL; Lu L; Zhou CX; Ma WB; Wang DM; Zhang SR
Zhonghua Zhong Liu Za Zhi; 2004 Mar; 26(3):158-60. PubMed ID: 15196436
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma angiogenin level is associated and may contribute to decreased T-cell zeta-chain expression in hemodialysis patients.
Eleftheriadis T; Kartsios C; Pissas G; Liakopoulos V; Antoniadi G; Galaktidou G; Stefanidis I
Ther Apher Dial; 2013 Feb; 17(1):48-54. PubMed ID: 23379493
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of signal-transducing zeta chain in peripheral T cells and natural killer cells in patients with cervical cancer.
Kono K; Ressing ME; Brandt RM; Melief CJ; Potkul RK; Andersson B; Petersson M; Kast WM; Kiessling R
Clin Cancer Res; 1996 Nov; 2(11):1825-8. PubMed ID: 9816136
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of activatory and inhibitory natural killer cell receptors in non-segmental vitiligo: a flow cytometric study.
Basak PY; Adiloglu AK; Koc IG; Tas T; Akkaya VB
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):970-6. PubMed ID: 18482314
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: decreased NKG2D and increased CD158a receptors on CD3-CD16+ NK cells.
Konjević G; Mirjacić Martinović K; Jurisić V; Babović N; Spuzić I
Biomarkers; 2009 Jun; 14(4):258-70. PubMed ID: 19489688
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.
Nakagomi H; Petersson M; Magnusson I; Juhlin C; Matsuda M; Mellstedt H; Taupin JL; Vivier E; Anderson P; Kiessling R
Cancer Res; 1993 Dec; 53(23):5610-2. PubMed ID: 8242612
[TBL] [Abstract][Full Text] [Related]
16. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
[TBL] [Abstract][Full Text] [Related]
17. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.
de Cal M; Cruz DN; Corradi V; Nalesso F; Polanco N; Lentini P; Brendolan A; Tetta C; Ronco C
Blood Purif; 2008; 26(3):249-54. PubMed ID: 18376106
[TBL] [Abstract][Full Text] [Related]
19. Increased natural killer cell activity in patients with an abdominal aortic aneurysm.
Forester ND; Cruickshank SM; Scott DJ; Carding SR
Br J Surg; 2006 Jan; 93(1):46-54. PubMed ID: 16315339
[TBL] [Abstract][Full Text] [Related]
20. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.
Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS
Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
